Digital Screening for Cervical Cancer in Cameroon
Part of Infections clinical trials.
This study tests a new digital imaging method to help screen women for cervical cancer risk in Cameroon. It may help catch cervical problems earlier using easier-to-read pictures of the cervix.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 25–49 years old (or 30–49 if HIV-negative)
- You are not currently pregnant
- You have not had your uterus (womb) surgically removed
- You do not have cervical cancer or symptoms like abnormal bleeding or pelvic lumps
- You can understand the study and agree to participate by signing a consent form
- You are willing and able to follow the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a mobile team approach to screen for cervical cancer using HPV testing in women living with HIV. It aims to make screening easier to access and more effective.
This trial tests two cervical screening approaches to find early signs of HPV-related changes. It may help by improving how results are sorted into “needs follow-up” versus “routine care,” especially for women with different HPV patterns.
This study checks whether a smartphone-based AI tool can help screen for cervical cancer. You may be offered the AI-assisted screening during a clinic visit to see if it works well when visualizing the cervix.
This study aims to improve how women living with HIV are screened and treated for cervical cancer in Kenya. It involves focus groups and a screening program to find better ways to prevent cancer.
This study is testing a new, non-invasive way to screen for cervical cancer. It uses a photoelectric device and an epigenetic test done on a sample from your cervix. The goal is to find early signs of cancer more accurately than current methods.
This trial tests a new, affordable way to screen for cervical cancer that can be done in low- and middle-income countries. It uses artificial intelligence to help decide who needs follow-up care.
Hear when a new Human Papillomavirus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.